drugset / Trial / NCT06176508
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study has been designed to explore the clinical efficacy and safety of HS-10374 in the treatment of active psoriatic arthritis. Additionally, this study is to find the optimal dosing for the future clinical development of HS-10374.
Timeline
- Start
- 2024-02-26
- Primary completion
- 2026-04-28
- Completion
- 2026-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10374 | Unknown | — | Oral |
| Comparator | Tofacitinib | Small molecule | 5 mg | Oral |